Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples